Valenza M - Search Results

1

Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease.

Xiang Z, Valenza M, Cui L, Leoni V, Jeong HK, Brilli E, Zhang J, Peng Q, Duan W, Reeves SA, Cattaneo E, Krainc D. Xiang Z, et al. Among authors: valenza m. J Neurosci. 2011 Jun 29;31(26):9544-53. doi: 10.1523/JNEUROSCI.1291-11.2011. J Neurosci. 2011. PMID: 21715619 Free PMC article.

2

Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease.

Valenza M, Rigamonti D, Goffredo D, Zuccato C, Fenu S, Jamot L, Strand A, Tarditi A, Woodman B, Racchi M, Mariotti C, Di Donato S, Corsini A, Bates G, Pruss R, Olson JM, Sipione S, Tartari M, Cattaneo E. Valenza M, et al. J Neurosci. 2005 Oct 26;25(43):9932-9. doi: 10.1523/JNEUROSCI.3355-05.2005. J Neurosci. 2005. PMID: 16251441 Free PMC article.

3

Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes.

Valenza M, Leoni V, Karasinska JM, Petricca L, Fan J, Carroll J, Pouladi MA, Fossale E, Nguyen HP, Riess O, MacDonald M, Wellington C, DiDonato S, Hayden M, Cattaneo E. Valenza M, et al. J Neurosci. 2010 Aug 11;30(32):10844-50. doi: 10.1523/JNEUROSCI.0917-10.2010. J Neurosci. 2010. PMID: 20702713 Free PMC article.

4

Emerging roles for cholesterol in Huntington's disease.

Valenza M, Cattaneo E. Valenza M, et al. Trends Neurosci. 2011 Sep;34(9):474-86. doi: 10.1016/j.tins.2011.06.005. Epub 2011 Jul 19. Trends Neurosci. 2011. PMID: 21774998 Review.

5

Whole body cholesterol metabolism is impaired in Huntington's disease.

Leoni V, Mariotti C, Nanetti L, Salvatore E, Squitieri F, Bentivoglio AR, Bandettini di Poggio M, Piacentini S, Monza D, Valenza M, Cattaneo E, Di Donato S. Leoni V, et al. Among authors: valenza m. Neurosci Lett. 2011 May 2;494(3):245-9. doi: 10.1016/j.neulet.2011.03.025. Epub 2011 Mar 22. Neurosci Lett. 2011. PMID: 21406216

6

Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington's disease.

Valenza M, Leoni V, Tarditi A, Mariotti C, Björkhem I, Di Donato S, Cattaneo E. Valenza M, et al. Neurobiol Dis. 2007 Oct;28(1):133-42. doi: 10.1016/j.nbd.2007.07.004. Epub 2007 Jul 10. Neurobiol Dis. 2007. PMID: 17702587

7

Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery.

Zuccato C, Liber D, Ramos C, Tarditi A, Rigamonti D, Tartari M, Valenza M, Cattaneo E. Zuccato C, et al. Among authors: valenza m. Pharmacol Res. 2005 Aug;52(2):133-9. doi: 10.1016/j.phrs.2005.01.001. Pharmacol Res. 2005. PMID: 15967378

8

Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list?

Valenza M, Cattaneo E. Valenza M, et al. Prog Neurobiol. 2006 Nov;80(4):165-76. doi: 10.1016/j.pneurobio.2006.09.005. Epub 2006 Oct 25. Prog Neurobiol. 2006. PMID: 17067733 Review.

9

Molecular mechanisms and potential therapeutical targets in Huntington's disease.

Zuccato C, Valenza M, Cattaneo E. Zuccato C, et al. Among authors: valenza m. Physiol Rev. 2010 Jul;90(3):905-81. doi: 10.1152/physrev.00041.2009. Physiol Rev. 2010. PMID: 20664076 Free article. Review.

10

Neuroprotection and brain cholesterol biosynthesis in Huntington's disease.

Valenza M, Cattaneo E. Valenza M, et al. Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):E143; author reply 144. doi: 10.1073/pnas.1006783107. Epub 2010 Aug 31. Proc Natl Acad Sci U S A. 2010. PMID: 20807740 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters